Depressive Disorder clinical trials
Access comprehensive clinical trial information for Depressive Disorder through Pure Global AI's free database. This collection includes 127 clinical trials across multiple phases including N/A, Phase 1, Phase 2. Currently, 21 trials are actively recruiting participants.
Research for Depressive Disorder is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include GlaxoSmithKline and Sanofi. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 127 clinical trials studying Depressive Disorder, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include GlaxoSmithKline, Sanofi, Shanghai Mental Health Center, among others.